Peter C. Lucas
Impact in
- Cancer Research top 0.5%
- NF-κB Signaling Pathways
- Breast Cancer Treatment Studies
- Immunology top 1%
- Immune Response and Inflammation
- Immune Cell Function and Interaction
Papers in
-
- Cancer Genomics and Diagnostics 30
- NF-κB Signaling Pathways 24
- Breast Cancer Treatment Studies 20
- Oncology 74
- Colorectal Cancer Treatments and Studies 35
- Cancer Immunotherapy and Biomarkers 13
- HER2/EGFR in Cancer Research 9
- Co-authors
- Ormond A. MacDougald (2 shared papers)Kenneth Longo (2 shared papers)Nahid Hemati (1 shared paper)Christina N. Bennett (1 shared paper)Robin L. Erickson (1 shared paper)Sarah E. Ross (1 shared paper)Gabriel Núñez (7 shared papers)Daryl K. Granner (6 shared papers)
- Journals
- Journal of Clinical Oncology (42 papers)Cancer Research (15 papers)Journal of Biological Chemistry (10 papers)Molecular and Cellular Biology (6 papers)Journal of Clinical Investigation (5 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Peter C. Lucas
158 papers receiving 8.4k citations
Peter C. Lucas's Hit Papers
Peers
Comparison fields: 5 of 124
- Cancer Research 2.2k
- Immunology 1.6k
- Oncology 1.5k
- Molecular Biology 3.9k
- Pathology and Forensic Medicine 780
Countries citing papers authored by Peter C. Lucas
This map shows the geographic impact of Peter C. Lucas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Lucas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Lucas more than expected).
Fields of papers citing papers by Peter C. Lucas
This network shows the impact of papers produced by Peter C. Lucas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Lucas. The network helps show where Peter C. Lucas may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter C. Lucas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 163 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of Adipogenesis by Wnt Signaling Hit paper breakdown → | 2000 | 1594 |
| 2 | 2000 | 456 | |
| 3 | 2007 | 424 | |
| 4 | 1990 | 327 | |
| 5 | 2001 | 326 | |
| 6 | 2004 | 301 | |
| 7 | 2002 | 229 | |
| 8 | 1995 | 200 | |
| 9 | 2005 | 189 | |
| 10 | 2002 | 183 | |
| 11 | 2001 | 178 | |
| 12 | 1992 | 159 | |
| 13 | 2001 | 152 | |
| 14 | 2004 | 148 | |
| 15 | The Great Immune Escape: Understanding the Divergent Immune Response in Breast Cancer Subtypes Hit paper breakdown → | 2022 | 147 |
| 16 | 2006 | 140 | |
| 17 | 2009 | 134 | |
| 18 | 2003 | 132 | |
| 19 | 1991 | 126 | |
| 20 | 2002 | 124 |
About Peter C. Lucas
Peter C. Lucas is a scholar working on Cancer Research, Oncology, Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 163 papers that have together received 8.5k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (35 papers), Cancer Genomics and Diagnostics (30 papers), Genetic factors in colorectal cancer (25 papers), NF-κB Signaling Pathways (24 papers), Breast Cancer Treatment Studies (20 papers), Cancer Immunotherapy and Biomarkers (13 papers), HER2/EGFR in Cancer Research (9 papers) and Prostate Cancer Treatment and Research (9 papers). The work is most often cited by research in Cancer Research (2.2k citations), Immunology (1.6k citations), Oncology (1.5k citations), Molecular Biology (3.9k citations) and Pathology and Forensic Medicine (780 citations). Peter C. Lucas has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Ormond A. MacDougald, Kenneth Longo, Nahid Hemati, Christina N. Bennett, Robin L. Erickson, Sarah E. Ross, Gabriel Núñez, Daryl K. Granner, Linda M. McAllister‐Lucas and Naohiro Inohara. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Journal of Biological Chemistry, Molecular and Cellular Biology and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.